Sodium ferric gluconate complex - AllerganAlternative Names: Ferrlecit
Latest Information Update: 15 Jul 2015
At a glance
- Originator Watson Pharmaceuticals
- Developer Allergan
- Class Antianaemics; Ferric compounds
- Mechanism of Action Iron replacements
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Iron deficiency anaemia